When I calculated my return for October, I thought I made a
calculation error. Everything kind of clicked… The growth stocks and merger arb
plays performed well. I’ll take it...
In terms of the growth stock portion of my portfolio,
Constellation Brands (Ticker: STZ
) once again delivered solid earnings and is trading near
its highs. This is also my largest holding making up ~ 26% of my portfolio.
Other companies such as Visa (Ticker: V
) and MasterCard (Ticker: MA
) have also performed well and are
also at new highs. And don’t forget about the biotechs such as Vertex Pharmaceuticals (Ticker: VRTX
Regeneron (Ticker: REGN
), which made a nice little bounce from the recent biotech sell off.
The merger arb plays are holding steady gains. The only position
that closed in October was Dealertrack. I was fortunate enough to get in the
day before the regulators approved the deal. That was just plain luck! I also
traded aggressively around some of the pre-merger plays such as Molson Coors (Ticker: TAP
SanDisk (Ticker: SNDK
) and Maxim Integrated Products (Ticker: MXIM
). My current merger arb portfolio is made
up of the following: Altera (Ticker: ALTR
), AirMedia (Ticker: AMCN
), BioMed Realty Trust (Ticker: BMR
), Integrated Silicon
Solution (Ticker: ISSI
), WuXi Pharmatech (Ticker: WX
) and Rite Aid Pharmacy (Ticker: RAD
I’ll be keeping a close eye on Integrated Silicon Solution
next week (CFIUS decision due by November 2nd) and looking forward
to the closing of WuXi Pharmatech sometime in December.
2015 Performance Year to Date = +29.68% with the
running monthly returns as follows: